MANCINI, MARIA VITTORIA
 Distribuzione geografica
Continente #
EU - Europa 384
NA - Nord America 172
AS - Asia 55
AF - Africa 1
Totale 612
Nazione #
IE - Irlanda 205
US - Stati Uniti d'America 172
IT - Italia 137
CN - Cina 42
FI - Finlandia 29
SG - Singapore 7
DE - Germania 5
JP - Giappone 4
CH - Svizzera 2
NL - Olanda 2
AT - Austria 1
DK - Danimarca 1
GB - Regno Unito 1
IN - India 1
NG - Nigeria 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 612
Città #
Dublin 205
Ashburn 39
Shanghai 37
Helsinki 29
New York 26
Saluzzo 22
Milan 20
Pavia 14
Trieste 13
Bergamo 12
Chandler 10
Piscataway 8
Turin 8
Camerino 6
Singapore 5
Como 4
Rome 4
Tokyo 4
Washington 4
Seattle 3
Amsterdam 2
Bologna 2
Brembate di Sopra 2
Brescia 2
Catania 2
Lodi 2
Los Angeles 2
Pognana Lario 2
Udine 2
Zurich 2
Boardman 1
Chelyabinsk 1
Edinburgh 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Jimo 1
Lagos 1
Marmirolo 1
Pune 1
San Martino in Strada 1
Sassari 1
St Louis 1
Vejle 1
Verona 1
Xi'an 1
Zhongshan 1
Totale 510
Nome #
Mapping the human genetic architecture of COVID-19 128
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study 30
Mosquitoes can harbour yeasts of clinical significance and contribute to their environmental dissemination 27
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study 24
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK 24
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 24
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort 23
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study 21
A microsporidian impairs Plasmodium falciparum transmission in Anopheles arabiensis mosquitoes 21
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study 19
Wolbachia in Aedes koreicus: Rare Detections and Possible Implications 18
Mutual exclusion of Asaia and Wolbachia in the reproductive organs of mosquito vectors 18
Phylogenomics reveals that asaia symbionts from insects underwent convergent genome reduction, preserving an insecticide-degrading gene 17
Mosquitoes can harbour yeasts of clinical significance and contribute to their environmental dissemination 17
Asaia activates immune genes in mosquito eliciting an anti-plasmodium response: Implications in malaria control 16
Asaia Paratransgenesis in Mosquitoes 15
Inhibition of asaia in adult mosquitoes causes male-specific mortality and diverse transcriptome changes 15
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19 15
Estimating bacteria diversity in different organs of nine species of mosquito by next generation sequencing 15
High Temperature Cycles Result in Maternal Transmission and Dengue Infection Differences between Wolbachia Strains in Aedes aegypti 14
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study 14
Enhancement of Aedes aegypti susceptibility to dengue by Wolbachia is not supported 14
Establishment of Wolbachia Strain wAlbB in Malaysian Populations of Aedes aegypti for Dengue Control 13
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination 12
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England 12
Genome reduction in the mosquito symbiont Asaia 11
Paratransgenesis to control malaria vectors: A semi-field pilot study 10
Wolbachia-Virus interactions and arbovirus control through population replacement in mosquitoes 9
Wolbachia strain wAu efficiently blocks arbovirus transmission in Aedes albopictus 9
Population‐specific responses to developmental temperature in the arboviral vector Aedes albopictus: Implications for climate change 8
Wolbachia strain wAlbB maintains high density and dengue inhibition following introduction into a field population of Aedes aegypti: Wolbachia wAlbB in wild Aedes aegypti 8
High promiscuity among females of the invasive pest species Drosophila suzukii 6
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses 6
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells 5
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study 5
Wolbachia strain wAlbB shows favourable characteristics for dengue control use in Aedes aegypti from Burkina Faso 4
Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model 3
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection 2
Totale 652
Categoria #
all - tutte 4.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023385 0 0 0 141 3 6 15 6 206 1 6 1
2023/2024255 44 25 14 19 20 52 36 9 0 15 14 7
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 652